Chemotherapy Drugs Current Events | Chemotherapy Drugs News | 2
|
| Page
2 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
Potential diagnostic marker indicates effectiveness of anti-angiogenic drugs
If an anti-angiogenic drug is successfully starving a cancer patient's tumor to death, the number of endothelial cells circulating in the individual's bloodstream will decrease, thus providing a potential biomarker for gauging the medication's effectiveness. view more (2006-09-18)
Study shows chemotherapy improves survival among older breast cancer patients
The average age of a woman diagnosed with breast cancer is 63, so it is critical to have effective proven, therapies for an older patient population. view more (2009-05-14)
Key to lung cancer chemo resistance revealed
Scientists at Johns Hopkins have discovered how taking the brakes off a "detox" gene causes chemotherapy resistance in a common form of lung cancer. view more (2006-10-11)
Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found. view more (2006-12-14)
Radiation after surgery doubles survival time for some lung cancer patients
Patients with lung cancer that has spread to mediastinal lymph nodes - located between the chest, breastbone and spine - who receive radiation after surgery and chemotherapy live twice as long as patients who do not receive radiation after surgery. view more (2006-11-07)
Inherited genes linked to toxicity of leukemia therapy
Investigators at St. Jude Children's Research Hospital have discovered inherited variations in certain genes that make children with acute lymphoblastic leukemia (ALL) susceptible to the toxic side effects caused by chemotherapy medications. view more (2007-05-14)
Delaying Chemotherapy Could Be Best Treatment Option For Certain Type Of Non-hodgkin Lymphoma (p 516)
Delaying chemotherapy until symptoms develop for patients with asymptomatic advanced low-grade non-Hodgkin lymphoma is confirmed as an appropriate strategy authors of a UK study in this week's issue of THE LANCET. Chemotherapy (single or aggressive combination therapy) does not cure advanced stage low-grade non-Hodgkin lymphomas, even when... view more... (2003-08-13)
Errors involving medications common in outpatient cancer treatment
Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications. view more (2009-01-05)
Inhibiting cell process may give cancer drug a boost
A molecule that interferes with the internal scaffolding that shapes the cell may kill cancer cells, retard the growth of tumors and give a boost to a common chemotherapy drug. view more (2006-05-04)
Survey reveals need for standardized oral chemotherapy prescribing practices, safeguards
Despite the widespread use of prescribing safeguards for infusion chemotherapy, few of those measures have been implemented with oral chemotherapy, according to a study led by researchers at Dana-Farber Cancer Institute. view more (2007-01-12)
Modest Survival Benefit From Chemotherapy For Patients With Glioma Brain Tumours (p 1011)
Chemotherapy in addition to radiotherapy could have a modest survival benefit for the treatment of high-grade glioma, a severe form of brain cancer, conclude authors of a study in this week's issue of THE LANCET. Malignant gliomas are among the most devastating of cancers. They frequently result in profound and progressive disability, which often... view more... (2002-03-20)
Benefit of chemotherapy in breast cancer depends on estrogen-receptor status
When it comes to chemotherapy treatment for women whose breast cancer has spread to their lymph nodes, the estrogen status of their tumors matters. view more (2006-04-12)
Bisphenol A linked to chemotherapy resistance
Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists. view more (2008-10-09)
Combination therapy shows improvement for breast cancer patients
Giving radiation therapy and chemotherapy at the same time after a lumpectomy helps keep breast cancer from returning locally. view more (2006-12-01)
Genomic signatures identify targeted therapies for lung cancer
Any number of things can go wrong in the cells of the body to cause cancer -- and clinicians can't tell by just looking at a tumor what exactly triggered the once normal cells to turn cancerous. view more (2007-06-04)
Melanoma treatment options 1 step closer
A targeted chemotherapy for the treatment of skin cancer is one step closer, after a team of University of Alberta researchers successfully synthesized a natural substance that shows exceptional potential to specifically treat this often fatal disease. view more (2009-10-21)
No benefit to increasing dose intensity of chemotherapy in osteosarcoma, study finds
A dose-intensive regimen of the chemotherapy drugs cisplatin and doxorubicin offered no clinical benefit over standard doses of the chemotherapy drugs in patients with a bone cancer called osteosarcoma, according to results from a randomized trial in the January 17 issue of the Journal of the National Cancer Institute. view more (2007-01-17)
Cell skeleton may hold key to overcoming drug resistance in cancer
Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients. view more (2007-10-04)
Adverse effects of chemotherapy may be under-reported
Young breast cancer patients who receive chemotherapy may have a higher number of serious side effects than reported in clinical trials. view more (2006-08-16)
Less-toxic drug prolongs survival in metastatic breast cancer
Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug. view more (2009-05-27)
|
|
| Page
2 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
|
